ITP
Conditions
Interventions
one:1. Drug therapy: including but not limited to corticosteroids, immunosuppressants, rituximab, thrombopoietin, etc.
two:Plasma exchange (PEX): For patients with refractory ITP, plasma exchange is a common treatment method.
three:Exploration of new therapies, such as the use of Caplacizumab (a nanobody against von Willebrand factor).
Sponsors
Chengqiang Jin
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients diagnosed with ITP, regardless of age or gender, willing to participate in the study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: Exclusion criteria: Other bleeding disorders, severe liver and kidney dysfunction, pregnant or lactating women, etc.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Incidence of bleeding events;Assessment of the quality of life;Treatment-related side effects; | — |
Primary
| Measure | Time frame |
|---|---|
| PLT count;HB concentration; | — |
Countries
China
Contacts
Public ContactChengqiang Jin
affiliated hospital of jining medical University
Outcome results
None listed